ArticleOncoimmunology

Azacytidine prevents experimental xenogeneic graft-versus-host disease without abrogating graft-versus-leukemia effects.

Grégory Ehx et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.